company background image
0RH2 logo

EL.En LSE:0RH2 Stock Report

Last Price

€11.41

Market Cap

€912.3m

7D

-4.2%

1Y

-2.6%

Updated

23 Apr, 2024

Data

Company Financials +

0RH2 Stock Overview

EL.En. S.p.A. engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally.

0RH2 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends2/6

EL.En. S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EL.En
Historical stock prices
Current Share Price€11.41
52 Week High€11.91
52 Week Low€8.29
Beta1.67
1 Month Change9.29%
3 Month Change20.87%
1 Year Change-2.65%
3 Year Change25.21%
5 Year Change151.32%
Change since IPO482.33%

Recent News & Updates

Recent updates

Shareholder Returns

0RH2GB Medical EquipmentGB Market
7D-4.2%-0.09%-0.9%
1Y-2.6%-10.7%-1.8%

Return vs Industry: 0RH2 exceeded the UK Medical Equipment industry which returned -10.7% over the past year.

Return vs Market: 0RH2 matched the UK Market which returned -1.8% over the past year.

Price Volatility

Is 0RH2's price volatile compared to industry and market?
0RH2 volatility
0RH2 Average Weekly Movement11.7%
Medical Equipment Industry Average Movement7.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0RH2's share price has been volatile over the past 3 months.

Volatility Over Time: 0RH2's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
19812,082n/aelengroup.com

EL.En. S.p.A. engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; EchoLaser, an integrated laser-ultrasound system that allows diagnosis and treatment of benign and malignant lesions; hair removal and non-invasive body contouring products; and laser sources and systems for cutting, welding, marking, and engraving on countless materials.

EL.En. S.p.A. Fundamentals Summary

How do EL.En's earnings and revenue compare to its market cap?
0RH2 fundamental statistics
Market cap€912.31m
Earnings (TTM)€48.24m
Revenue (TTM)€692.29m

18.9x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0RH2 income statement (TTM)
Revenue€692.29m
Cost of Revenue€440.21m
Gross Profit€252.08m
Other Expenses€203.84m
Earnings€48.24m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 15, 2024

Earnings per share (EPS)0.60
Gross Margin36.41%
Net Profit Margin6.97%
Debt/Equity Ratio16.1%

How did 0RH2 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

33%

Payout Ratio

Does 0RH2 pay a reliable dividends?

See 0RH2 dividend history and benchmarks
When do you need to buy 0RH2 by to receive an upcoming dividend?
EL.En dividend dates
Ex Dividend DateMay 20 2024
Dividend Pay DateMay 22 2024
Days until Ex dividend26 days
Days until Dividend pay date28 days

Does 0RH2 pay a reliable dividends?

See 0RH2 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.